Patient and medication‐related factors associated with opioid use disorder after inpatient opioid administration

Background Examine baseline factors associated with a new diagnosis of opioid use disorder (OUD) within 12 months postdischarge among opioid‐naïve patients who received an opioid prescription in the inpatient setting. Design/Setting Retrospective cohort (surgery and nonsurgery) study of opioid‐naive...

Full description

Saved in:
Bibliographic Details
Published inJournal of hospital medicine Vol. 17; no. 5; pp. 342 - 349
Main Authors Swart, Elizabeth C.S., Newman, Terri V., Huang, Yan, Howell, Robert J., Han, Mei, Good, Chester B., Peasah, Samuel K., Parekh, Natasha
Format Journal Article
LanguageEnglish
Published United States Frontline Medical Communications 01.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Examine baseline factors associated with a new diagnosis of opioid use disorder (OUD) within 12 months postdischarge among opioid‐naïve patients who received an opioid prescription in the inpatient setting. Design/Setting Retrospective cohort (surgery and nonsurgery) study of opioid‐naive patients who had at least one prescription for an opioid during an inpatient hospitalist between 2014 and 2017. Participants Twenty‐three thousand and thirty‐three patients were included. Objective The primary objective was to determine baseline factors associated with a new OUD diagnosis within 12 months of discharge. Baseline covariates included demographic information, clinical characteristics, medication use, characteristics related to index hospital encounter, and discharge location. Findings 2.1% of the sample had a new diagnosis of OUD within a year after receiving an opioid during hospital admission. Patients between ages 25 and 34 had higher odds of a new OUD diagnosis compared to those 65 years of age and older (odds ratio [OR]: 6.98, 95% confidence interval [CI]: 4.02–12.1 [nonsurgery] and 4.69, 95% CI: 2.63–8.37 [surgery]). Patients from a high opioid geo‐rank region had higher odds of OUD diagnosis (OR: 2.08, 95% CI: 1.31–3.31 [nonsurgery] and 1.80, 95% CI: 1.03–3.15 [surgery]). History of nonopioid‐related drug disorder, tobacco use disorder, mental health conditions, and gabapentin use 12 months prior to index date and white race were associated with higher odds of new OUD diagnosis. Conclusions It is important to identify and evaluate factors associated with developing a new diagnosis of OUD following hospitalization. This can inform pain management strategies within the hospital and at discharge, and prompt clinicians to screen for risk of OUD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1553-5592
1553-5606
DOI:10.1002/jhm.12835